Skip to content
Logo MNL Group
    • The Maqui
    • What is Maqui Berry
    • Science Behind Maqui
    • Delphinol®
    • MaquiBright®
    • Futerpenol®
    • About MNL Group
    • Global Partners & Clients
    • Sustainability & Sourcing
    • Our Process
  • Literature
  • News & Articles
  • Contact
OUR PRODUCTS

MAQUIBRIGHT® - Clinically Proven Eye Hydration & Cellular Protection

A standardized Maqui extract rich in delphinidins — the world’s most powerful antioxidant molecules — clinically validated to support tear fluid balance and ocular comfort.

NATURAL ORIGIN. SCIENTIFIC PRECISION.

Science Meets Ocular Wellness

MaquiBright® is a patented standardized extract obtained from the wild Maqui Berry (Aristotelia chilensis), native to the forests of Patagonia.
 
It contains ≥ 25 % delphinidins, rare anthocyanins that protect ocular cells from oxidative stress caused by UV radiation, pollution, and prolonged screen exposure.
 
Through over a decade of research, MNL Group developed MaquiBright® to address a modern health challenge: chronic eye dryness and digital fatigue.
 
See Clinical Studies
LACRIMALGLANDS

Mechanisms of action

Tear Fluid Production

Stimulates lacrimal gland secretion, improving eye moisture and comfort.


Double-blind study, Takara Clinic, Japan – +25 % tear fluid vs placebo after 4 weeks.

Oxidative Stress Protection

Neutralizes free radicals and lipid peroxidation in ocular and dermal tissues.


In vitro study – delphinidins protect corneal cells under oxidative conditions. 

LACRIMALGLANDS-maqui

Clinical Validation

Ocular Health – Dry Eye Relief

  • 25 % increase in tear fluid production (60 mg/day, 4 weeks).
  • ~75 % reduction in dry-eye symptom severity after 60 days.
  • Improved oxidative protection of lacrimal gland cells via delphinidin D3G5G bioavailability.
All trials conducted under double-blind, placebo-controlled conditions in Japan, Italy, and Brazil (Takara Clinic, J. Am. Coll. Nutr., Clin. Cosmet. Investig. Dermatol.).

Standardization & Composition

More about MNL Group

Each batch of MaquiBright® is standardized to:
≥ 25 % delphinidins
≥ 35 % total anthocyanins
Full traceability from wild Maqui harvests in Southern Chile

Key Components:
Delphinidin 3,5-diglucoside (D3G5G)
Delphinidin 3-sambubioside-5-glucoside (D3S5G)
Polyphenols, flavonoids, and natural fibers

Patent:
WO 2014/098092 — Dry Eye Treatment Composition.

MaquiBright®

Applications

maqui-pills-1
    • Dry-eye and screen-fatigue formulations
    • Anti-aging capsules and functional powders
    • Eye-health shots, gummies, and drinks enriched with MaquiBright®.

Sustainaibility & Origin


MaquiBright® is sustainably sourced from Patagonia’s wild Maqui forests, harvested by local Chilean families under fair-trade and traceability standards.


MNL’s agricultural plan (2024–2028) transitions from 99 % wild collection to sustainable cultivation (90–110 ha), ensuring biodiversity conservation and consistent quality supply.

 

Sustainability and science working together to protect both vision and the environment.

Sustainability in MNL Group
sicence-maqui-berry
SCIENCE. SAFETY. STANDARDIZATION.

Why MaquiBright®

  • Clinically proven to increase tear fluid and reduce oxidative damage.
  • Naturally rich in delphinidins — the most powerful antioxidant anthocyanins.
  • Backed by global patents and peer-reviewed clinical studies.
  • Produced with sustainable, traceable sourcing from Patagonia.
More about Maqui Science
CONTACT US

Partner with the Leaders in Maqui Berry Science

Discover how our standardized Maqui extracts can elevate your formulations with clinically validated antioxidant power.

MNL-products
Logo MNL Group

Follow us and get in touch to stay up to date with our latest news.

 

+56 222 479 647

Av. del Valle 576, of 504, Huechuraba, Santiago, Chile

  • Maqui Berry
    • The Maqui
    • What is Maqui Berry
    • Science Behind Maqui
  • Products
    • Delphinol®
    • MaquiBright®
    • Futerpenol®
  • Company
    • About MNL Group
    • Global Partners & Clients
    • Sustainability & Sourcing
    • Our Process

MNL GROUP Copyright 2026   |   All rights reserved 

 
Terms of Services   |    Privacy Policy